You Position: Home > Paper
Safety of topical tacrolimus: an update
( views:406, downloads:121 )
- Author:
- No author available
- Journal Title:
- International Journal of Dermatology and Venereology
- Issue:
- 2
- DOI:
- 10.3760/cma.j.issn.1673-4173.2012.02.005
- Key Word:
- 他克莫司;安全;投药,局部;Tacrolimus;Safety;Administration,topical
Abstract： Tacrolimus is a macrolide immunosuppressant.The action mechanisms of tacrolimus are similar to that of cyclosporine.Since the molecular weight is low,tacrolimus can penetrate the epidermal barrier.Topical tacrolimus shows favorable efficacy in the treatment of atopic dermatitis and other T cellmediated dermatoses,and has been regarded as a new treatment alternative for skin diseases.The safety of long-term use of tacrolimus has attracted more and more attention because of its severe immunosuppressive effects and some potential problems of systemic absorption.Data are limited on the systemic evaluation of adverse reactions of topical tacrolimus.The authors review recent reports on side effects of topical tacrolimus at home and abroad,in hope to promote its proper use.
- [1]史天陆,孙言才,沈爱宗,等.他克莫司临床不良反应与防治[J].2009,(1).
- [2]Markus, B?hm,Uta, Frieling,Thomas A, Luger,etc.Successful treatment of anogenital lichen sclerosus with topical tacrolimus.[J].2003,139.
- [3]A, Allen,E, Siegfried,R, Silverman,etc.Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome.[J].2001,137(6).
- [4]Ulf, Mattsson,Bengt, Magnusson,Mats, Jontell.Squamous cell carcinoma in a patient with oral lichen planus treated with topical application of tacrolimus.[J].2010,110(1).
- [5]Y. Niwa,T. Terashima,H. Sumi.Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin[J].2003,149(5).
- [6]Mandelin, Johanna,Anita Remitz,Hannele Virtanen,etc.One-year Treatment with 0.1% Tacrolimus Ointment versus a Corticosteroid Regimen in Adults with Moderate to Severe Atopic Dermatitis: A Randomized, Double-blind, Comparative Trial.[J].2010,90(2).
- [7]Maarten, Naesens,Dirk R J, Kuypers,Minnie, Sarwal.Calcineurin inhibitor nephrotoxicity.[J].2009,4(2).
- [8]Ring J,Mohrenschlager M,Henkel V.The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.[J].2008,31(3).
- [9]Stuetz A,Fresneau M,Moenius T,etc.Binding of pimecrolimus and tacrolimus to skin and plasma proteins: implications for systemic exposure after topical application.[J].2008,36(9).
- [10]Verena von Felbert,Monika Hampl,Carolina Talhari,etc.Squamous cell carcinoma arising from a localized vulval lesion of Hailey-Hailey disease after tacrolimus therapy[J].2010,203(3).
- [11]Jürgen C Becker,Roland Houben,Claudia S VetterEva B Bröcker.The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report[J].2006,6(1).
- [12]Alomar A,Jackson K,Smith C,etc.A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis.[J].2005,124(4).
- [13]Reitamo Sakari.Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis[J].2000.
- [14]ANNALISA PATRIZI,IRIA NERI,FEDERICA BIANCHI,etc.Facial Eruption of Viral Warts in a Child Treated with 0.03% Tacrolimus Ointment for Atopic Dermatitis[J].2007,24(4).
- [15]McCollum AD,Paik A,Eichenfield LF.The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.[J].2010,27(5).
- [16]Maryann, Mikhail,Jedd, Wolchok,Stacie M, Goldberg,etc.Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus.[J].2008,144(4).
- [17]Ambo,Midori.Relapsing Kaposi's Varicelliform Eruption and Herpes Simplex Following Facial Tacrolimus Treatment for Atopic Dermatitis.[J].2002,82(3).
- [18]Bilenchi R,Poggiali S,De-Padova LA,etc.Human papillomavirus reactivation following topical tacrolimus therapy of anogenital lichen sclerosus.[J].2007,156(2).
- [19]Rothman KJ,Tennis P,Gelfand JM.Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors.[J].2011,165(3).
- [20]Hultsch T,Kapp A,Spergel J.Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.[J].2005,211(2).
- [21]Ekberg H,Bernasconi C,Noldeke J,etc.Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.[J].2010,25(6).
- [22]Lubbe J,Pournaras CC,Saurat JH.Eczema herpeticum during treatment of atopic dermatitis with 0.1; tacrolimus ointment.[J].2000,201(3).
- [23]Osawa K,Etoh T,Ariyoshi N,etc.Relationship between Kaposi's varicelliform eruption in Japanese patients with atopic dermatitis treated with tacrolimus ointment and genetic polymorphisms in the IL-18 gene promoter region.[J].2007,34(8).